These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 21971458
1. The merits of FDDNP-PET imaging in Alzheimer's disease. Shin J, Kepe V, Barrio JR, Small GW. J Alzheimers Dis; 2011; 26 Suppl 3():135-45. PubMed ID: 21971458 [Abstract] [Full Text] [Related]
2. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB. Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246 [Abstract] [Full Text] [Related]
3. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease. Shin J, Lee SY, Kim SH, Kim YB, Cho SJ. Neuroimage; 2008 Nov 01; 43(2):236-44. PubMed ID: 18694837 [Abstract] [Full Text] [Related]
4. PET of brain amyloid and tau in mild cognitive impairment. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR. N Engl J Med; 2006 Dec 21; 355(25):2652-63. PubMed ID: 17182990 [Abstract] [Full Text] [Related]
5. 2-(1-{6-[(2-[fluorine-18]fluoroethyl)(methyl) amino]-2-naphthyl} ethylidene)malononitrile (FDDNP) positron emission tomography patterns in nondemented populations. Shin J, Lee SY. Am J Geriatr Psychiatry; 2010 Feb 21; 18(2):187; author reply 188. PubMed ID: 20104075 [No Abstract] [Full Text] [Related]
6. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, Huang SC, Barrio JR, Ercoli LM, Siddarth P, Satyamurthy N, Liu J, Toga AW, Bookheimer SY, Small GW, Thompson PM. Neurobiol Aging; 2010 Oct 21; 31(10):1669-78. PubMed ID: 19004525 [Abstract] [Full Text] [Related]
7. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR. Am J Geriatr Psychiatry; 2002 Oct 21; 10(1):24-35. PubMed ID: 11790632 [Abstract] [Full Text] [Related]
8. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment. Barrio JR, Kepe V, Satyamurthy N, Huang SC, Small G. J Nutr Health Aging; 2008 Jan 21; 12(1):61S-5S. PubMed ID: 18165848 [Abstract] [Full Text] [Related]
9. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Small GW, Siddarth P, Burggren AC, Kepe V, Ercoli LM, Miller KJ, Lavretsky H, Thompson PM, Cole GM, Huang SC, Phelps ME, Bookheimer SY, Barrio JR. Arch Gen Psychiatry; 2009 Jan 21; 66(1):81-7. PubMed ID: 19124691 [Abstract] [Full Text] [Related]
10. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL. Brain; 2014 Jun 21; 137(Pt 6):1762-71. PubMed ID: 24681664 [Abstract] [Full Text] [Related]
11. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A. J Neurochem; 2009 Apr 21; 109(2):623-30. PubMed ID: 19226369 [Abstract] [Full Text] [Related]
12. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. Lavretsky H, Siddarth P, Kepe V, Ercoli LM, Miller KJ, Burggren AC, Bookheimer SY, Huang SC, Barrio JR, Small GW. Am J Geriatr Psychiatry; 2009 Jun 21; 17(6):493-502. PubMed ID: 19472439 [Abstract] [Full Text] [Related]
13. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease. Kepe V, Huang SC, Small GW, Satyamurthy N, Barrio JR. Methods Enzymol; 2006 Jun 21; 412():144-60. PubMed ID: 17046657 [Abstract] [Full Text] [Related]
14. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile. Agdeppa ED, Kepe V, Petri A, Satyamurthy N, Liu J, Huang SC, Small GW, Cole GM, Barrio JR. Neuroscience; 2003 Jun 21; 117(3):723-30. PubMed ID: 12617976 [Abstract] [Full Text] [Related]
15. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR. J Neurosci; 2001 Dec 15; 21(24):RC189. PubMed ID: 11734604 [Abstract] [Full Text] [Related]
16. Psychological well-being and regional brain amyloid and tau in mild cognitive impairment. Chen ST, Siddarth P, Saito NY, Rueda F, Haight T, Ercoli LM, Miller KJ, Lavretsky H, Barrio JR, Bookheimer SY, Small GW, Merrill DA. Am J Geriatr Psychiatry; 2014 Apr 15; 22(4):362-9. PubMed ID: 23567426 [Abstract] [Full Text] [Related]
17. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans. Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC. J Nucl Med; 2010 Feb 15; 51(2):210-8. PubMed ID: 20080894 [Abstract] [Full Text] [Related]
18. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease. Ono M, Saji H. J Pharmacol Sci; 2012 Feb 15; 118(3):338-44. PubMed ID: 22382657 [Abstract] [Full Text] [Related]
19. Differential FDDNP PET patterns in nondemented middle-aged and older adults. Ercoli LM, Siddarth P, Kepe V, Miller KJ, Huang SC, Cole GM, Lavretsky H, Bookheimer SY, Kim J, Phelps ME, Barrio JR, Small GW. Am J Geriatr Psychiatry; 2009 May 15; 17(5):397-406. PubMed ID: 19390297 [Abstract] [Full Text] [Related]
20. Seeing is believing: neuroimaging adds to our understanding of cerebral pathology. Small GW, Kepe V, Barrio JR. Curr Opin Psychiatry; 2006 Nov 15; 19(6):564-9. PubMed ID: 17012932 [Abstract] [Full Text] [Related] Page: [Next] [New Search]